The FDA is planning to allow Americans to receive a COVID-19 booster made by a different drugmaker than the one that made the vaccine with which they were initially inoculated, The New York Times reported Oct. 18.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,